ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 26 Oct 2009
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
78822817 filed on 24th Feb 2006
Registration Number
N/A
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KINENZAK
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, n Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, pain, reproductive disorders and urological disorders
Mark Details
Serial Number
No 78822817
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 15353
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Oct 2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 26th Oct 2009 | ABANDONMENT - NO USE STATEMENT FILED |
| 09th Mar 2009 | EXTENSION 5 GRANTED |
| 06th Mar 2009 | EXTENSION 5 FILED |
| 06th Mar 2009 | TEAS EXTENSION RECEIVED |
| 18th Sep 2008 | EXTENSION 4 GRANTED |
| 18th Sep 2008 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 16th Sep 2008 | TEAS EXTENSION RECEIVED |
| 16th Sep 2008 | EXTENSION 4 FILED |
| 25th Mar 2008 | EXTENSION 3 GRANTED |